Investigation of antibody-drug conjugates of a novel target
Ended Cooperative Agreement Awarded Last action
- Award ID
- R41CA213479
- Recipient
-
Wntrix, Inc. UEI HE6LHLBVCLY5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Houston, TX 77021, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R41CA213479?
R41CA213479 was awarded to Wntrix, Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2017.
How much is award R41CA213479 worth?
$225,000 has been obligated on R41CA213479.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award